This site is intended for healthcare professionals only

Professor Anna Strömberg

Professor of Nursing Science, Linköping University, and Research Coordinator and Heart Failure Nurse Specialist, Department of Cardiology, Linköping University Hospital

Linköping, Sweden

Biography

Professor Anna Strömberg is Professor of Nursing Science at Linköping University and Linköping University Hospital, Sweden. Her research and clinical guidance has led to implementation of nurse-led heart failure clinics throughout Europe, and she has been involved in the development of a nursing curriculum for European heart failure nurses. She has developed computer-based educational materials for patients (www.heartfailurematters.org), which are available in eight languages and with more translations in progress. Her research has contributed to international clinical guidelines, and she has served on guideline committees for heart failure care. She leads two large research programmes, ‘Information and communication technology to support self-care in chronic illness’ and ‘User driven innovation: Symptom monitoring after hospitalisation in patients with advanced heart failure – a NordicBaltic study’, and, together with Professor Tiny Jaarsma, leads a large research group in cardiovascular nursing with more than 15 PhD students, 5 postdocs and many international visiting scholars.

The overall aim for her research is to develop methods and models for follow-up; to develop psychoeducational support for patients with cardiovascular disease and their families; and to evaluate their effects on self-care, health-related quality of life, participation, perceived control, survival and healthcare utilisation. Professor Strömberg has a long-standing commitment within the European Society of Cardiology, working to increase the impact of cardiovascular nursing. She is the Co-Editor of the European Journal of Cardiovascular Nursing.

Disclosures

Dr Strömberg has received consultancy honoraria from Novartis. She has received honoraria as a speaker from Vifor Pharma, ResMed and Novartis.